Psychiatry and Clinical Psychopharmacology
Case Report

Visual hallucination induced by duloxetine use: a male case diagnosed with generalized anxiety disorder

1.

Department of Child and Adolescent Psychiatry, Firat University Medical Faculty, Elazig, Turkey

Psychiatry and Clinical Psychopharmacology 2018; 28: 346-348
DOI: 10.1080/24750573.2017.1419421
Read: 1650 Downloads: 588 Published: 09 February 2021

Duloxetine is a serotonin-noradrenaline reuptake inhibitor. It has been increasingly used in child and adolescent psychiatric practice in recent years. In this paper, we presented a 16-year-old male patient diagnosed with generalized anxiety disorder who had developed visual hallucinations after treatment with duloxetine. The visual hallucinations resolved after duloxetine were stopped. To the best of our knowledge, this is the first reported case from the adolescent age group who described visual hallucinations during duloxetine treatment.

Files
EISSN 2475-0581